Insulin resistance (IR), a key metabolic disorder in aging, exacerbates mitochondrial dysfunction by inhibiting AMP-activated protein kinase (AMPK) and weakens the antioxidant effect of nuclear factor erythroid 2-related factor 2 (Nrf2). This evidence concerns the gene NFE2L2 and metabolic disease.